3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Neoplasms
3
Sarcoma
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Multiple Myeloma
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Stomatitis
1
Rectal Diseases
1
Pancreatic Diseases
1
Oligodendroglioma
1
Neoplasms, Plasma Cell
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Motor Activity
1
Lung Neoplasms
1
Liver Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphoid
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Inflammation
1
Graft vs Host Disease
1
Gliosarcoma
1
Interventions
fludarabine phosphate
15
Whole-Body Irradiation
9
Peripheral Blood Stem Cell Transplantation
9
Mycophenolic Acid
9
Cyclophosphamide
8
Busulfan
8
Tacrolimus
7
Cyclosporine
5
ruxolitinib
4
fludarabine
4
Methotrexate
4
Antilymphocyte Serum
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
peginterferon alfa-2a
2
givinostat hydrochloride
2
givinostat
2
Stem Cell Transplantation
2
Radiotherapy
2
Melphalan
2
Etoposide
2
Carboplatin
2
veliparib
1
thymoglobulin
1
sonidegib
1
pomalidomide
1
merphos
1
bomedemstat
1
anagrelide
1
Transplantation
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thrombocythemia, Essential
×
Ascorbic Acid
×
Clear all
No trials found.